OncoGenex Regains Rights to Custirsen from Teva

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. GNK
3. NVDA
4. AZN
5. SPCX
6. FNGR
7. PLUR
8. EYPT
9. HIVE
10. GSAT

Go back to OncoGenex Regains Rights to Custirsen from Teva
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) Delayed: 0.40 --0 (-0%)
Previous Close $0.40    52 Week High $2.80 
Open $0.05    52 Week Low $0.33 
Day High $0.40    P/E N/A 
Day Low $0.40    EPS $-1.98 
Volume 500       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.57 -0.2 (0.54%)
Previous Close $36.77    52 Week High $66.55 
Open $36.53    52 Week Low $37.82 
Day High $36.70    P/E N/A 
Day Low $35.99    EPS $0.00 
Volume 1,373,088       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.57 -0.2 (0.54%)
Previous Close $36.77    52 Week High $66.55 
Open $36.53    52 Week Low $37.82 
Day High $36.70    P/E N/A 
Day Low $35.99    EPS $0.00 
Volume 1,373,088